Consequently, the Keap1–Nrf2 system has emerged as an important therapeutic target in cancer and neurodegenerative conditions, as well as many autoimmune and inflammatory diseases [2], [4], [5], [16], [22]. The gene discussed is KEAP1; the disease is cancer.